June 12, 2026 · Form 4 insider transaction
Agarwal Arjun bought 1,459 shares of Oruka Therapeutics, Inc. at $34.39 per share, a transaction worth $50.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.